Overview

Honey and Nigella Sativa in COVID-19 Prophylaxis

Status:
Recruiting

Trial end date:
2022-04-15

Target enrollment:

Participant gender:

Summary

Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Sohaib Ashraf